(Reuters) -AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma, showing clinically meaningful improvement in lung function. The Anglo-Swedish drugmaker’s therapy, …
AstraZeneca Korea said Friday that it has signed a memorandum of understanding (MOU) with AI-based software startup Oncosoft to enhance the diagnosis and assessment of the rare disease neurofibromatosis type 1 (NF1). The agreement seeks to expand treatment …
AstraZeneca on Tuesday confirmed it has closed down its neuroscience research group to direct resources toward more “high value” projects. On an earnings call with investors, Sharon Barr, AstraZeneca’s head of biopharmaceuticals research and development, …
Credit: Adobestock.com The big business announcements: AstraZeneca axes phase III prostate cancer trial AstraZeneca is discontinuing a phase III trial of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) in …
New Delhi: UK pharma major AstraZeneca in partnership with health-tech company Qure.ai, announced the completion of 5 million artificial intelligence (AI) enabled chest X-rays (CXRs) across more than 20 countries in Asia, the Middle East, Africa, and Latin …
Image used for representation purpose only. | Photo Credit: x-reflexnaja AstraZeneca and health-tech company Qure.ai have completed the risk assessment of 5 million artificial intelligence (AI)-enabled chest X-rays (CXRs) across more than 20 countries in …
When I first started writing for The Motley Fool more than two decades ago, the GSK (LSE: GSK) share price was a FTSE 100 shining light. In my recollection, GlaxoSmithKline, as it was known then, even outshone pharmaceutical sector rival AstraZeneca (LSE: …
AstraZeneca’s (LSE: AZN) share price has fallen significantly from its 3 September one-year traded high of £133.38. Some of this drop resulted from an investigation of its Chinese business. The firm said in its Q1 2025 results released on 29 April that …
British-Swedish pharmaceutical giant AstraZeneca plc is facing increasing scrutiny in China, with authorities accusing the company of evading more than $1.6 million in import taxes as part of a widening smuggling investigation that now includes a top- …
&
03 days 09:25:01
